在淋巴细胞疾病中减少葡萄糖皮质激素
Michael Toal1, Mark Canney1,2, Caitlin Hesketh1
1Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Kidney international reports
|February 24, 2026
概括
葡萄糖皮质类药物 (GCs) 对质细胞疾病至关重要,但有毒性. 本综述表明,在ANCA相关的血管炎,狼性炎和IgA病中,GC节约策略可以减少暴露,同时保持有效性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质类药物 (Glucocorticoids,简称GCs) 是由于其强烈的抗炎作用而导致球细胞疾病的主要治疗方法.
- 由于GC的毒性,需要减少累积暴露,并探索替代策略.
- 综述综合了主要质细胞疾病中GC节约方法的证据.
研究的目的:
- 为了评估GC节约策略在质细胞疾病中的有效性和安全性.
- 确定最佳的降低GC疗法和新的治疗整合.
- 为未来的临床实践提供有关GC在病学中的使用的信息.
主要方法:
- 随机对照试验和关键非对照研究的系统审查.
- 对抗中性细胞细胞体抗体 (ANCA) 相关的血管炎 (AAV),狼性炎 (LN),最小变化疾病 (MCD) 和IgA脏病 (IgAN) 中GC节约策略的分析.
- 评估PEXIVAS和LoVAS等试验的证据.
主要成果:
- 在AAV中减少剂量的GC疗法保持有效性并降低感染风险.
- 在LN中,低剂量的GC与向药物 (贝利马布,氨酸抑制剂,奥比努图祖马布) 结合,可促进更快的逐渐减少.
- 与氨酸抑制剂或mycophenolate结合疗法在MCD中以较少的类固醇暴露实现缓解;IGAN实践从GC转移.
- GCs越来越多地用于早期的,时间有限的诱导,在选择的质细胞病变.
结论:
- 虽然GC在某些炎症性淋巴结核病的诱导中仍然是必不可少的,但它们的作用正在缩小.
- 节省GC的策略是有效的,并降低了各种质细胞疾病中的毒性.
- 需要对IV甲基prednisolone进行进一步的研究,以快速呈现甚至更低剂量的GC疗法.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
568
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
568
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
650
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
650
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.7K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
598
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
598
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
277
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
277


